A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Moderna, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 31,069 shares of MRNA stock, worth $1.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,069
Previous 30,387 2.24%
Holding current value
$1.25 Million
Previous $3.61 Million 42.46%
% of portfolio
0.01%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $43,402 - $85,345
682 Added 2.24%
31,069 $2.08 Million
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $203,735 - $335,385
-2,013 Reduced 6.21%
30,387 $3.61 Million
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $2.77 Million - $3.74 Million
32,400 New
32,400 $3.32 Billion
Q4 2023

Aug 14, 2024

SELL
$69.51 - $104.43 $24,884 - $37,385
-358 Reduced 1.12%
31,592 $3.14 Billion
Q3 2023

Aug 14, 2024

SELL
$96.41 - $126.61 $433,170 - $568,858
-4,493 Reduced 12.33%
31,950 $3.3 Billion
Q2 2023

Aug 14, 2024

SELL
$118.5 - $160.53 $1.24 Million - $1.68 Million
-10,492 Reduced 22.35%
36,443 $4.43 Billion
Q1 2023

Aug 14, 2024

BUY
$135.66 - $197.02 $182,327 - $264,794
1,344 Added 2.95%
46,935 $7.21 Billion
Q4 2022

Aug 14, 2024

SELL
$118.38 - $210.04 $666,124 - $1.18 Million
-5,627 Reduced 10.99%
45,591 $8.19 Billion
Q3 2022

Aug 14, 2024

BUY
$118.07 - $194.18 $70,251 - $115,537
595 Added 1.18%
51,218 $6.06 Billion
Q2 2022

Aug 14, 2024

BUY
$117.13 - $176.59 $421,433 - $635,370
3,598 Added 7.65%
50,623 $7.23 Billion
Q1 2022

Aug 14, 2024

BUY
$126.46 - $235.05 $2.1 Million - $3.91 Million
16,638 Added 54.75%
47,025 $8.1 Billion
Q4 2021

Aug 30, 2024

SELL
$225.82 - $368.51 $235,756 - $384,724
-1,044 Reduced 2.27%
44,991 $11.4 Billion
Q3 2021

Aug 30, 2024

BUY
$221.9 - $484.47 $722,728 - $1.58 Million
3,257 Added 7.61%
46,035 $17.7 Billion
Q2 2021

Aug 30, 2024

BUY
$129.91 - $234.98 $1.61 Million - $2.91 Million
12,391 Added 40.78%
42,778 $10 Billion
Q1 2021

Aug 30, 2024

SELL
$109.18 - $185.98 $475,478 - $809,942
-4,355 Reduced 7.83%
51,276 $6.72 Billion
Q4 2020

Aug 30, 2024

BUY
$65.74 - $169.86 $3.5 Million - $9.04 Million
53,220 Added 2207.38%
55,631 $5.81 Billion
Q3 2020

Aug 30, 2024

BUY
$54.34 - $94.85 $64,447 - $112,492
1,186 Added 96.82%
2,411 $171 Million
Q2 2020

Aug 30, 2024

BUY
$29.67 - $80.0 $31,895 - $86,000
1,075 Added 716.67%
1,225 $78.7 Million
Q1 2020

Aug 30, 2024

SELL
$17.78 - $31.58 $537,613 - $954,884
-30,237 Reduced 99.51%
150 $4.49 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.